Alemtuzumab Induction Therapy in Elderly Kidney Transplant Recipients.

被引：0
|
作者：
Yakubu, I. [1 ]
Masters, B. [1 ]
Ravichandran, B. [1 ]
Sparkes, T. [1 ]
Moss, M. [1 ]
Rasetto, F. [1 ]
Jonchhe, S. [1 ]
Thomas, B. [2 ]
Costa, N. [2 ]
Leeser, D. [2 ]
Bartlett, S. [2 ]
Haririan, A. [2 ]
机构：
[1] Univ Maryland, Med Ctr, Pharm, Baltimore, MD 21201 USA
[2] Univ Maryland, Med Ctr, Baltimore, MD 21201 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2016年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
C38
引用
收藏
页码：613 / 614
页数：2
相关论文
共 50 条
  • [31] Experience with Thymoglobulin® induction therapy in pancreas transplant recipients.
    Wiland, AM
    Fink, JC
    Philosophe, B
    Farney, AC
    Schweitzer, EJ
    Colonna, JO
    Weir, MR
    Bartlett, ST
    TRANSPLANTATION, 2000, 69 (08) : S408 - S408
  • [32] Comparison of Anti-Thymocyte Globulin and Alemtuzumab as Induction Therapy in Older Kidney Transplant Recipients
    Chaung, M.
    Hollinger, E.
    Brokhof, M.
    Alvey, N.
    Lineberger, L.
    Kenyon, N.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 916 - 916
  • [33] Long Term Outcomes With Alemtuzumab Induction Therapy for Deceased and Living Renal Transplant Recipients. A Single Center Experience
    Vaitla, P.
    Patel, U.
    Cruz, A.
    Guisti, S.
    Moiz, A.
    Catherine, C. -S.
    Cohen, A.
    Loss, G.
    Bohorquez, H.
    Carmody, I.
    Reichman, T.
    Bruce, D.
    Anders, S.
    Garces, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [34] INFLAMMATORY NEUROPATHY AFTER ALEMTUZUMAB THERAPY IN KIDNEY TRANSPLANT RECIPIENTS
    van der Zwan, Marieke
    Hesselink, Dennis A.
    Brusse, Esther
    van Doorn, Pieter A.
    van den Hoogen, Martijn W. F.
    de Weerd, Annelies E.
    Jacobs, Bart C.
    TRANSPLANTATION, 2020, 104 (09) : S382 - S382
  • [35] Induction with Alemtuzumab Should Be Weight Adjusted To Achieve Optimal Outcomes in Renal Transplant Recipients.
    Chan, K.
    Charif, R.
    Galliford, J.
    Goodall, D.
    Hakim, N.
    McLean, A.
    Roufosse, C.
    Cook, T.
    Papalois, V.
    Taube, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 314 - 314
  • [36] Induction Therapy in Elderly Kidney Transplant Recipients with Low Immunological Risk.
    Masset, C.
    Boucquemont, J.
    Garrigue, V.
    Ladriere, M.
    Buron, F.
    Cassuto, E.
    Foucher, Y.
    Dantal, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 816 - 816
  • [37] Induction Therapy in Low Risk Elderly Kidney Transplant Recipients: Donor Factors
    Al Ammary, F.
    DeMarco, M.
    Huang, Q.
    King, E.
    Bay, S.
    Muzaale, A.
    Wiseman, A.
    Segev, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 354 - 354
  • [38] Alemtuzumab in Kidney-Transplant Recipients
    Markmann, James F.
    Fishman, Jay A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (20): : 1968 - 1969
  • [39] Alemtuzumab in Kidney-Transplant Recipients
    Luan, Fu L.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (07): : 671 - 671
  • [40] Thymoglobulin induction therapy does not increase risk of BK virus replication in kidney transplant recipients.
    Wong, WC
    Hirsch, HH
    Fujimoto, K
    Pascual, M
    Doran, MT
    Delvecchio, AM
    Cosimi, AB
    Tolkoff-Rubin, N
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 197 - 197
12345